FI955312A0 - Staurosporiinijohdannaisen intravenoosit liuokset - Google Patents

Staurosporiinijohdannaisen intravenoosit liuokset

Info

Publication number
FI955312A0
FI955312A0 FI955312A FI955312A FI955312A0 FI 955312 A0 FI955312 A0 FI 955312A0 FI 955312 A FI955312 A FI 955312A FI 955312 A FI955312 A FI 955312A FI 955312 A0 FI955312 A0 FI 955312A0
Authority
FI
Finland
Prior art keywords
straurosporine
derivatives
intravenous solutions
intravenous
solutions
Prior art date
Application number
FI955312A
Other languages
English (en)
Swedish (sv)
Other versions
FI955312A (fi
Inventor
Hans Georg Weder
Ute Isele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI955312A0 publication Critical patent/FI955312A0/fi
Publication of FI955312A publication Critical patent/FI955312A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
FI955312A 1994-11-09 1995-11-06 Staurosporiinijohdannaisen intravenoosit liuokset FI955312A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH337594 1994-11-09
CH59595 1995-03-02

Publications (2)

Publication Number Publication Date
FI955312A0 true FI955312A0 (fi) 1995-11-06
FI955312A FI955312A (fi) 1996-05-10

Family

ID=25685065

Family Applications (2)

Application Number Title Priority Date Filing Date
FI955311A FI955311A (fi) 1994-11-09 1995-11-06 Farmaseuttinen koostumuspohja
FI955312A FI955312A (fi) 1994-11-09 1995-11-06 Staurosporiinijohdannaisen intravenoosit liuokset

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI955311A FI955311A (fi) 1994-11-09 1995-11-06 Farmaseuttinen koostumuspohja

Country Status (11)

Country Link
US (1) US5658898A (fi)
EP (2) EP0711557A1 (fi)
JP (2) JPH08208486A (fi)
KR (2) KR960016890A (fi)
AU (2) AU3661795A (fi)
CA (2) CA2162342A1 (fi)
FI (2) FI955311A (fi)
HU (2) HUT78026A (fi)
IL (2) IL115912A0 (fi)
NO (2) NO954485L (fi)
NZ (2) NZ280419A (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
WO1997021428A1 (de) * 1995-12-12 1997-06-19 Vesifact Ag Cortisolspray zur topischen verabreichung
DE19622224A1 (de) 1996-02-16 1997-08-21 Max Planck Gesellschaft Phosphatidyloligoglycerine
DE69738416T2 (de) * 1996-06-18 2008-12-11 Kyowa Hakko Kogyo Co., Ltd. Liposomale zubereitungen von indolocarbazol-derivaten
WO1998037869A1 (fr) * 1997-02-27 1998-09-03 Nippon Shinyaku Co., Ltd. Emulsion grasse s'administrant par voie orale
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US7381423B2 (en) 1998-05-11 2008-06-03 Ciba Specialty Chemicals Corp. Use of nanodispersions in cosmetic end formulations
TW592713B (en) * 1998-05-11 2004-06-21 Ciba Sc Holding Ag Use of nanodispersions in cosmetic end formulations
TWI241915B (en) 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) * 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
DE69929128T2 (de) * 1998-08-31 2006-06-29 Nipro Corp. Nährstoffinfusionspräparat
GB9903547D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
GB9924962D0 (en) * 1999-10-21 1999-12-22 Mrc Collaborative Centre Allosteric sites on muscarinic receptors
PT1441737E (pt) 2001-10-30 2006-12-29 Dana Farber Cancer Inst Inc Derivados de estrutura como inibidores da actividade do receptor de tirosina cinase flt3
KR100422763B1 (ko) * 2002-01-17 2004-03-12 주식회사 태평양 경피흡수 촉진 능력이 우수한 식물성 나노입자의 제조 및이를 함유하는 화장료 및 의약용 외용제 조성물
KR100490365B1 (ko) * 2002-04-25 2005-05-17 한불화장품주식회사 화장료용 나노 베지클을 함유하는 화장료 조성물
EP2319493A3 (en) * 2002-07-23 2011-07-27 Novartis AG Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR101032281B1 (ko) * 2003-03-03 2011-05-06 플로리안 랑 진단 및 치료 표적으로서의 ｓｇｋ１
GB0305941D0 (en) * 2003-03-14 2003-04-23 Camurus Ab Composition
BRPI0413439A (pt) 2003-08-08 2006-10-17 Novartis Ag combinações compreendendo estaurosporinas
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
JP5135852B2 (ja) * 2007-03-30 2013-02-06 日油株式会社 可溶化用組成物
KR100849537B1 (ko) * 2007-07-04 2008-07-31 유효경 코엔자임 큐텐의 나노에멀젼 조성물
WO2009067221A2 (en) * 2007-11-20 2009-05-28 Cephalon, Inc. Microemulsion containing indolocarbazole compound and dosage forms containing the same
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP2787977A4 (en) * 2011-12-09 2015-05-06 Univ California LIPOSOMAL ACTIVE INVERTING
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk １−〔２−（２，４−ジクロロフエニル）−３−メチル−１−ペンテニル〕−１ｈ−イミダゾ−ルを含有する水中油型脂肪乳剤
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
CH677886A5 (fi) * 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
AU675930B2 (en) * 1992-02-18 1997-02-27 Pharmos Corp. Dry compositions for preparing submicron emulsions
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions

Also Published As

Publication number Publication date
CA2162341A1 (en) 1996-05-10
HU9503198D0 (en) 1996-01-29
CA2162342A1 (en) 1996-05-10
JPH08208522A (ja) 1996-08-13
NO954485L (no) 1996-05-10
NZ280419A (en) 1997-04-24
IL115912A0 (en) 1996-01-31
AU3661795A (en) 1996-05-23
AU3661695A (en) 1996-05-23
EP0711557A1 (de) 1996-05-15
HUT78026A (hu) 1999-05-28
EP0711556A1 (de) 1996-05-15
NO954486L (no) 1996-05-10
FI955311A (fi) 1996-05-10
HUT74423A (en) 1996-12-30
IL115913A0 (en) 1996-01-31
FI955312A (fi) 1996-05-10
NZ280420A (en) 1997-03-24
US5658898A (en) 1997-08-19
FI955311A0 (fi) 1995-11-06
KR960016890A (ko) 1996-06-17
NO954485D0 (no) 1995-11-08
NO954486D0 (no) 1995-11-08
HU9503199D0 (en) 1996-01-29
KR960016908A (ko) 1996-06-17
JPH08208486A (ja) 1996-08-13

Similar Documents

Publication Publication Date Title
FI955312A0 (fi) Staurosporiinijohdannaisen intravenoosit liuokset
DE69321403D1 (de) Dialysegerät
ATA75293A (de) Indolderivate
DE69307979T2 (de) Ansaugkatheteranordnungen
TR199501209A2 (tr) Urea türevleri
ATE166584T1 (de) Anschlussstück
DE69124732D1 (de) Mehrlumiger Katheter
DE69305952D1 (de) Ansaugkatheteranordnungen
NO932146D0 (no) Benzimidazolderivater
DE69330497D1 (de) Chinazolin-derivate
DE69329894T2 (de) Arylamidderivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
DE69304645D1 (de) Kanuele
FI931868A0 (fi) Finishingblandning foer yta
BR9508339A (pt) Medicamento
ITMI922776A1 (it) Soluzioni crioprotettrici
NO952288D0 (no) Benzazepinon-derivater
DE69331111D1 (de) INTRAVENöSE KANüLENEINHEIT
DE69313890T2 (de) 5-Aminoflavon-Derivate
DE69320910D1 (de) Saugkatheteraufbauten
DE69522857D1 (de) Insulinstandardlösung
DE69132145T2 (de) Peritoneal wirksame medikamente
FI972204A (fi) Suonensisäisiä lubelutsoliliuoksia
DE69210389D1 (de) Pumpenanordnung
KR940006763U (ko) 광전식 자동점멸장치

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG